Draft guidance stresses need for quality in development of gene therapies
The EMA has released draft guidelines to aid the gene therapy developers, many of which it says are small companies not familiar with the regulatory environment.
Archives for May 24, 2015
CROs look to buttress research models businesses with CRISPR/Cas tech
As the largest pharma and tech suppliers – from Novartis to GE Healthcare to Thermo Fisher – begin exploring the world of CRISPR/Cas gene editing technology, contract research organizations are also looking into the new tech to explore ways to help...